Addex Therapeutics Ltd (ADXN)
8.15
-0.35 (-4.12%)
At close: Mar 03, 2025, 3:12 PM
8.25
1.23%
After-hours: Mar 03, 2025, 02:54 PM EST
Addex Therapeutics Ltd Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Revenue | 1.61M | 1.42M | 2.92M | 3.61M | 2.76M | 6.04M | 499.89K | 17.33K | 40.3K | 85.4K | 91.76K | 121.09K | 2.82M | 1.98M | 4.09M | 26.81M | 486.93K | 4.74M |
| Cost of Revenue | 6.94M | 14.62M | 12.82M | 10.37M | 230.1K | 144.17K | 29.76K | 17.33K | 40.3K | 85.4K | 91.76K | 1.27M | 27.99M | 31.16M | n/a | n/a | -156.03K | n/a |
| Gross Profit | -5.32M | -13.2M | -9.9M | -6.76M | 2.53M | 5.9M | 470.13K | n/a | n/a | n/a | n/a | -1.15M | -25.16M | -29.19M | 4.09M | 26.81M | 642.96K | 4.74M |
| Operating Income | -10.28M | -20.52M | -15.51M | -12.24M | -14.83M | -1.42M | -3.24M | -3.13M | -3.87M | -1.8M | -14.46M | -27.01M | -30.97M | -33.6M | -43.05M | -24.87M | -37.62M | -20.9M |
| Interest Income | 63.96K | 29.25K | 5.32K | 35.3K | 36.87K | 85.87K | n/a | 27.00 | 39.86K | 1.59K | 4.13K | 22.66K | 72.2K | 97.25K | 362.13K | 3.31M | 2.55M | 241.99K |
| Pretax Income | -10.56M | -20.8M | -15.35M | -12.86M | -14.78M | -1.64M | -3.28M | -3.15M | -4.2M | -1.77M | -14.46M | -26.61M | -31.14M | -33.65M | 42.69M | -22.07M | -35.09M | -20.54M |
| Net Income | -10.56M | -20.8M | -15.35M | -12.86M | -14.78M | -1.64M | -3.28M | -3.15M | -4.2M | -1.77M | -14.46M | -26.61M | -31.14M | -33.65M | -42.69M | -22.07M | -35.09M | -20.54M |
| Selling & General & Admin | 7.2M | 7.3M | 5.14M | 5.15M | 4.26M | 4.72M | 2.2M | 1.52M | 1.57M | 1.55M | 6.47M | 12.85M | 6.73M | 6.43M | 7.6M | 7.55M | 10.77M | n/a |
| Research & Development | 2.75M | 14.67M | 12.84M | 10.37M | 12.45M | 2.37M | 841.31K | 819.33K | 761.22K | 258.06K | 2.22M | 4.76M | 4.76M | 31.16M | 39.96M | 44.19M | 12.21M | 9.77M |
| Other Expenses | 1.94M | -22.52K | 444K | 336.68K | 648.16K | 382.99K | 197.67K | 799.7K | 311.82K | -9.44K | 5.77M | 9.4M | -919.55K | -2.02M | n/a | -67.33K | 25.9M | 15.98M |
| Operating Expenses | 11.89M | 21.94M | 18.42M | 15.86M | 17.37M | 7.47M | 3.24M | 3.14M | 2.64M | 1.8M | 14.46M | 27.01M | 5.81M | 35.57M | 47.56M | 51.68M | 38.11M | 25.76M |
| Interest Expense | 21.61K | 48.9K | 63.01K | 69.5K | 128.52K | 220.17K | 45.35K | 6.92K | 152.21K | n/a | n/a | n/a | 239.37K | 144.81K | n/a | 501.88K | 8.54K | 30.45K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 11.89M | 21.94M | 18.42M | 15.86M | 17.37M | 7.47M | 3.24M | 3.14M | 2.64M | 1.8M | 14.46M | 27.01M | 33.8M | 35.57M | 47.56M | 51.68M | 38.11M | 25.76M |
| Income Tax | n/a | 123.91K | 116.38K | 207.76K | 429.01K | 1.00 | n/a | 6.92K | 152.21K | -21.68K | 3.23K | -398.93K | 72.2K | 97.25K | 171.13M | 3.31M | 2.54M | 346.91K |
| Shares Outstanding (Basic) | 74.31M | 45.18M | 34.12M | 26.68M | 26.43M | 23.29M | 12.94M | 11.41M | 10.85M | 9.98M | 9.07M | 7.91M | 1.24M | 986.06K | 955.78K | 956.03K | 836.15K | 476.53K |
| Shares Outstanding (Diluted) | 74.31M | 45.18M | 34.12M | 26.68M | 26.43M | 23.29M | 12.94M | 11.41M | 10.85M | 9.98M | 9.07M | 7.91M | 1.24M | 986.06K | 955.78K | 956.03K | 836.15K | 476.53K |
| EPS (Basic) | -0.14 | -0.46 | -0.45 | -0.48 | -0.56 | -0.07 | -0.25 | -0.28 | -0.39 | -0.18 | -1.6 | -3.36 | -25.14 | -34.12 | -44.67 | -23.08 | -41.96 | -43.11 |
| EPS (Diluted) | -0.14 | -0.46 | -0.45 | -0.48 | -0.56 | -0.07 | -0.25 | -0.28 | -0.39 | -0.18 | -1.6 | -3.36 | -25.14 | -34.12 | -44.67 | -23.08 | -41.96 | -43.11 |
| EBITDA | -10.23M | -20.23M | -14.94M | -12.41M | -14.32M | -1.51M | -3.22M | -3.12M | -2.61M | -1.71M | -13.79M | -24.87M | -28.05M | -30.56M | -39.86M | -19.55M | -33.26M | -17.99M |
| Depreciation & Amortization | 305.95K | 323.14K | 347.61K | 378.75K | 333.84K | 2.94K | 15.25K | 25.76K | 25.88K | 110.14K | 662.55K | 2.1M | 2.93M | 2.94M | 2.84M | 2.02M | 1.8M | 2.52M |